Med-Chemist : "Quintessential Medicinal Chemistry"
Monday, December 18, 2017
Antimalarial drugs could find another use as cancer treatments, study says
›
Antimalarial drugs chloroquine and hydroxychloroquine could find another use as cancer treatments, according to a new clinical study publi...
Thursday, December 14, 2017
Tesaro Announces U.S. FDA Approval of Varubi IV for Delayed Nausea and Vomiting Associated With Cancer Chemotherapy
›
In continuation of my update on Varubi (rolapitant) Tesaro, Inc. an oncology-focused biopharmaceutical company, today announced t...
Wednesday, December 13, 2017
Noden Pharma Announces FDA Approval of Tekturna (aliskiren) Oral Pellets for the Treatment of Hypertension in Adults and Children 6 Years of Age and Older
›
In continuation of my update on Tekturna (aliskiren) Noden Pharma DAC, a global specialty pharmaceutical company that is focused ...
Tuesday, December 12, 2017
Over-the-counter decongestant found to be effective inhibitor of tumor stroma
›
In continuation of my update on N-Acetyl cysteine - or NAC CANCER researchers seeking non-toxic alternatives to harmful chemotherapy...
Novo Nordisk Receives FDA Approval of Ozempic (semaglutide) Injection For the Treatment of Adults with Type 2 Diabetes
›
Novo Nordisk today announced that the U.S. Food and Drug Administration (FDA) approved its New Drug Application (NDA) for Ozempic (semaglu...
Monday, December 11, 2017
FDA Approves Sutent (sunitinib malate) for Adjuvant Treatment of Adult Patients at High Risk of Recurrent Renal Cell Carcinoma
›
In continuation of my update on Sunitib The U.S. Food and Drug Administration today approved Sutent (sunitinib malate) for the adjuv...
Friday, December 8, 2017
FDA Approves Juluca (dolutegravir and rilpivirine) for the Maintenance Treatment of Virologically Suppressed HIV-1 Infection
›
In continuation of my update on dolutegravir and rilpivirine The U.S. Food and Drug Administration today approved Juluca , the fir...
Thursday, December 7, 2017
Tesaro Announces U.S. FDA Approval of Varubi IV for Delayed Nausea and Vomiting Associated With Cancer Chemotherapy
›
In continuation of my update on rolapitant Tesaro, Inc., an oncology-focused biopharmaceutical company, announced that th...
Wednesday, December 6, 2017
Seaweed-derived compound may offer possible solution for sun protection
›
A compound found in seaweed could protect human skin from the damaging impact of the sun without causing harm to marine ecosystems. Th...
FDA Approves Zelboraf (vemurafenib) for Erdheim-Chester Disease with BRAF V600 Mutation
›
In continuation of my update on Vemurafenib The U.S. Food and Drug Administration today expanded the approval of Zelboraf (vemurafenib...
Tuesday, December 5, 2017
FDA Approves Vyzulta (latanoprostene bunod) Ophthalmic Solution for Open-Angle Glaucoma, Ocular Hypertension
›
Valeant Pharmaceuticals International, Inc.'s announced that the U.S. Food and Drug Administration (FDA) has approved the New Dr...
Monday, December 4, 2017
Novel drug combination could enhance immunotherapy responses in patients with lung cancer
›
In continuation of my update on 5-azacytidine Johns Hopkins Kimmel Cancer Center researchers and colleagues have identified a novel d...
FDA Approves Alecensa (alectinib) as First-Line Treatment for ALK-Positive Metastatic Non-Small Cell Lung Cancer
›
Genentech, a member of the Roche Group announced that the U.S. Food and Drug Administration (FDA) approved the supplemental New Drug Appl...
Drug that stimulates neuron pruning promotes goal-directed behavior in mice
›
A drug that stimulates neuron pruning can nudge mice away from habit-driven behaviors when combined with retraining, neuroscientists have ...
Friday, December 1, 2017
FDA Approves Prevymis (letermovir) for Prevention of Cytomegalovirus (CMV) Infection and Disease in Adult Allogeneic Stem Cell Transplant Patients
›
Merck & Co., Inc. , announced that the U.S. Food and Drug Administration (FDA) has approved Prevymis ( letermovir ) once-daily tab...
‹
›
Home
View web version